The Broad-Spectrum Anti-Emetic Activity of the Novel Non-Peptide Tachykinin NK1 Receptor Antagonist GR203040

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.1995.tb15118.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

(±)-Cp-96,345, a Selective Tachykinin NK1 Receptor Antagonist, Has Non-Specific Actions on Neurotransmission

British Journal of Pharmacology
Pharmacology
1992English

Effects of CP-96,345, a Novel Non-Peptide Antagonist of NK1 Receptor, on the Peristalsis in Isolated Guinea Pig Ileum.

The Japanese Journal of Pharmacology
1992English

Tachykinin Precursor 1 (TAC1; NK1; NK2); Tachykinin Receptor 1 (TACR1; NK1R)

Science-Business eXchange
2009English

Anti-Inflammatory Properties of a Novel Peptide Interleukin 1 Receptor Antagonist

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

Effect of TAK-637, a Tachykinin NK1-Receptor Antagonist, on Lower Urinary Tract Function in Cats.

The Japanese Journal of Pharmacology
2001English

Structure–Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2003English

Peptide Extract From Olivancillaria Hiatula Exhibits Broad-Spectrum Antibacterial Activity

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Two Active Molecular Phenotypes of the Tachykinin NK1 Receptor Revealed by G-Protein Fusions and Mutagenesis

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy